- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Apremilast – November 2015
Apremilast: tablets, 10 mg, 20 mg, 30 mg, Otezla®
Last updated
4 March 2016